Lawrence Steinman

ULTIMATE I & II results: ublituximab versus teriflunomide in relapsing MS 3:27
ULTIMATE I & II results: ublituximab versus teriflunomide in relapsing MS
Lawrence Steinman • 11 Jun 2021
Novel agents are needed for the treatment of multiple sclerosis 3:08
Novel agents are needed for the treatment of multiple sclerosis
Lawrence Steinman • 11 Jun 2021
The content of VJNeurology is intended for healthcare professionals